Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.40 |
| ▸ | PPARG | P37231 | 7/20 | 0.40 |
| ▸ | PPARD | Q03181 | 7/20 | 0.40 |
| ▸ | PPARA | Q07869 | 7/20 | 0.40 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.40 |
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | TLR2 | O60603 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | FABP4 | P15090 | 2/20 | 0.40 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.40 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | PDE4A | P27815 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5859801 | 0.97 | AKR1B1 (0.40) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL9177227 | 0.97 | AKR1B1 (0.40) | AKR1B1GPR84PPARGPPARDPPARA | |
| Hydrogen Sulfide SCHEMBL28242647 | 0.97 | AKR1B1 (0.40) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL9181451 | 0.97 | AKR1B1 (0.40) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL9177480 | 0.97 | CES2 (0.40) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL2347926 | 0.95 | AKR1B1 (0.39) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL2136858 | 0.95 | AKR1B1 (0.39) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL9182204 | 0.95 | CES2 (0.43) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL2136284 | 0.95 | AKR1B1 (0.44) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL1115982 | 0.95 | AKR1B1 (0.44) | AKR1B1GPR84PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 232 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3993715-B1 | IMPLANTATION NEEDLE FOR INSERTING A SUBCUTANEOUSLY INSERTABLE ELEMENT INTO A BODY TISSUE | HOFFMANN LA ROCHE (CH) | 2024-04-17 | — | — | EP | claimed |
| US-20230210868-A1 | Methods of Treatment Using ICAM-Modulating Agents | AVM BIOTECHNOLOGY, LLC (US) | 2023-07-06 | — | — | US | claimed |
| CN-116216035-A | Printing packaging box with degradation function and production process thereof | 深圳市宏景天科技研发有限公司 | 2023-06-06 | — | — | CN | claimed |
| CN-109646708-B | Preparation method of medical adhesive tape | 宁波六麦新材料科技有限公司 | 2021-07-02 | — | — | CN | claimed |
| CN-112851919-A | 1,4, 3, 6-diglycidyl hexaol modified PET polyester and semi-continuous preparation method thereof | 中国科学院化学研究所 | 2021-05-28 | — | — | CN | claimed |
| CN-111269540-A | Special high-concentration flame-retardant master batch for polylactic acid and preparation method thereof | 宿迁联盛科技股份有限公司 | 2020-06-12 | — | — | CN | claimed |
| US-20170346129-A1 | ELECTROCHEMICAL DEVICES COMPRISING NANOSCOPIC CARBON MATERIALS MADE BY ADDITIVE MANUFACTURING | GRAPHENE 3D LAB INC. (US) | 2017-11-30 | — | — | US | claimed |
| WO-2017189947-A1 | PHARMACEUTICAL DOSAGE FORMS | ASCENT PHARMACEUTICALS, INC. (US) | 2017-11-02 | — | — | WO | claimed |
| US-20170312226-A1 | PHARMACEUTICAL DOSAGE FORMS | ASCENT PHARMA INC (US) | 2017-11-02 | — | — | US | claimed |
| WO-2016036607-A1 | ELECTROCHEMICAL DEVICES COMPRISING NANOSCOPIC CARBON MATERIALS MADE BY ADDITIVE MANUFACTURING | GRAPHENE 3D LAB INC. (US) | 2016-03-10 | — | — | WO | claimed |
| CN-102924494-A | Novel organic oximido silicon compound and preparation method and application thereof | BEIJING TONSAN NEW MATERIAL TECHNOLOGY CO LTD | 2013-02-13 | — | — | CN | claimed |
| EP-1722741-B1 | DENTAL MATERIAL BASED ON ALKOXYSILYL-FUNCTIONAL POLYETHERS | KETTENBACH GMBH & CO KG (DE) | 2009-04-01 | — | — | EP | claimed |
| US-20070173557-A1 | Dental material based on alkoxysilyl-functional polyethers containing a salt of a strong base as catalyst | KETTENBACH GMBH & CO. KG (DE) | 2007-07-26 | — | — | US | claimed |
| EP-1722741-A1 | DENTAL MATERIAL BASED ON ALKOXYSILYL-FUNCTIONAL POLYETHERS | Kettenbach GmbH & CO. KG (DE) | 2006-11-22 | — | — | EP | claimed |
| WO-2005077321-A1 | DENTAL MATERIAL BASED ON ALKOXYSILYL-FUNCTIONAL POLYETHERS | KETTENBACH GMBH & CO. KG (DE) | 2005-08-25 | — | — | WO | claimed |
| US-6027748-A | OF DRUGS EXHIBITING A DIFFERENT BIOLOGICAL ABSORPTION RATE IN THE PRESENCE AND IN THE ABSENCE OF FOOD; COMPRISING A CORE HAVING ONE OR A CORE HAVING LAYERS OF ERODIBLE, GELLABLE HYDROPHILIC POLYMER BARRIERS; ACID-RESISTANT COATING | JAGOTEC AG (CH) | 2000-02-22 | — | — | US | claimed |
| EP-0951905-A2 | Pharmaceutical compositions for programmed therapeutical coverage | APR APPLIED PHARMA RESEARCH S.A. (CH) | 1999-10-27 | — | — | EP | claimed |
| EP-0321950-B1 | Combination of pyrimidine derivatives and hydrocortisone to induce and stimulate the hair growth and to reduce hair loss | OREAL (FR) | 1994-01-12 | — | — | EP | claimed |
| EP-0321950-A1 | Combination of pyrimidine derivatives and hydrocortisone to induce and stimulate the hair growth and to reduce hair loss | L'OREAL (FR) | 1989-06-28 | — | — | EP | claimed |
| EP-0321951-A1 | Combination of pyrimidine derivatives and fluorized steroidal anti-inflammatory agents to induce and stimulate the hair growth and to reduce hair loss | L'OREAL (FR) | 1989-06-28 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070173557-A1 | Dental material based on alkoxysilyl-functional polyethers containing a salt of a strong base as catalyst | CSNK1A1L, TBL3, DCLK3 | AKR1B1 3278/4885GPR84 2340/4885PPARG 1142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.